XBiotech director John Simard buys $711,000 of shares
Open market purchase reported on Form 4, filed Oct 28, 2026.
Snapshot
John Simard, a director of XBiotech (XBIT), bought 368,524 shares in open market purchases on Oct 26, 2026, about $711,000 at an average price of $1.93 a share, according to a Form 4 filed with the SEC on Oct 28, 2026.
- Independent Research
Market Data
| Company | 1D % | Price |
|---|---|---|
| ($XBIT) | ▼ −4.77% | 1.90 |
as of 14:30 ET · Realtime derived data
What We Know
The filing lists 1 open market purchase line: • Oct 26, 2026: 368,524 shares at $1.93.
After the last purchase, the filing reports 4,191,690 shares held directly in that account.
Octans View
The purchases raised the holding reported in that account by about 9.6%, computed from the filed share counts. An open market purchase is made with the insider's own money at the market price, unlike option exercises or stock awards, which this brief excludes. The filing does not say why the insider bought.
Bear Case · Room for Disagreement
Limits. Insiders must report trades within two business days; this brief covers one filing and does not net it against sales by the same person or other insiders. Prices are as filed; where a line shows a weighted average, the filing's footnotes give the range.
Method and source. Octans Research reads the structured Form 4 filed with the SEC, keeps open market purchases (code P) only, and computes the total value and the average price from the filed share counts and prices. The filed price must sit within 25% of the closing price on the trade date. The text is generated by a fixed template; no model wrote it.
Chart
Sources
- [1]SEC EDGAR — Form 4 filed by John Simard for XBiotech, Oct 28, 2026
These are the sources this piece was drafted from. How we verify. Found an error? Tell us and we correct it in public.
More on $XBIT
4 reports
Ttm Technologies director Wajid Ali buys $902,000 of shares
Open market purchase reported on Form 4, filed Oct 28, 2026.
Bluerock Private Real Estate Fund director Ramin Kamfar buys $2.2 million of shares
Open market purchase reported on Form 4, filed Oct 28, 2026.
Accenture CEO Julie Spellman Sweet buys $3.0 million of shares
Open market purchase reported on Form 4, filed Oct 28, 2026.
Gold.com 10% owner Tether Global Investments Fund S.I.C.A.F. S.A. buys $3.9 million of shares
Open market purchase reported on Form 4, filed Oct 28, 2026.